Recent News

• 09.09.2026 - Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures
• 09.09.2026 - Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures
• 09.08.2026 - Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience
• 09.08.2026 - Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience
• 09.01.2026 - Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference
• 09.01.2026 - Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference
• 08.12.2026 - Shoulder Innovations announces $4.9M expansion to Byron Center
• 08.10.2026 - Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer
• 08.10.2026 - Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer
• 08.06.2026 - Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook

Recent Filings

• 08.28.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.24.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.17.2026 - 144 Report of proposed sale of securities
• 08.13.2026 - EFFECT Notice of Effectiveness
• 08.10.2026 - 3 Initial statement of beneficial ownership of securities
• 08.10.2026 - 8-K Current report
• 08.10.2026 - EX-99.1 EX-99.1
• 08.07.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 08.07.2026 - 4 Statement of changes in beneficial ownership of securities